|
|
|
Insider
Information: |
Pasqualone Frank |
Relationship: |
|
City: |
South San Francisco |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
3 |
|
Direct
Shares |
454,562 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$4,279,073 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
454,562 |
|
|
Total
Value |
$4,279,073 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Innoviva Inc |
INVA |
Sr. Vice President, Op... |
2014-01-23 |
20,000 |
2014-01-23 |
0 |
Premium* |
|
Theravance Biopharma, Inc. |
TBPH |
SVP, Chief Business Of... |
2021-08-20 |
433,562 |
2015-02-05 |
0 |
Premium* |
|
Enveric Biosciences Ord Shs |
ENVB |
|
2023-09-15 |
1,000 |
2023-09-15 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
ENVB |
Enveric Biosciences Ord S... |
|
|
2023-09-15 |
4 |
B |
$2.14 |
$2,140 |
D/D |
1,000 |
1,000 |
0.01 |
- |
|
TBPH |
Theravance Biopharma, Inc... |
SVP, Chief Business Officer |
|
2021-08-20 |
4 |
D |
$14.05 |
$53,095 |
D/D |
(3,779) |
433,562 |
0 |
- |
|
TBPH |
Theravance Biopharma, Inc... |
SVP, Chief Business Officer |
|
2021-05-20 |
4 |
D |
$17.80 |
$67,266 |
D/D |
(3,779) |
437,341 |
0 |
- |
|
TBPH |
Theravance Biopharma, Inc... |
SVP, Chief Business Officer |
|
2021-02-20 |
4 |
D |
$18.79 |
$506,597 |
D/D |
(26,961) |
439,719 |
0 |
- |
|
TBPH |
Theravance Biopharma, Inc... |
SVP, Chief Business Officer |
|
2021-02-08 |
4 |
A |
$0.00 |
$0 |
D/D |
65,000 |
466,680 |
0 |
- |
|
TBPH |
Theravance Biopharma, Inc... |
SVP, Chief Comm Ops Officer |
|
2020-11-20 |
4 |
D |
$17.21 |
$72,523 |
D/D |
(4,214) |
401,680 |
0 |
- |
|
TBPH |
Theravance Biopharma, Inc... |
SVP, Chief Comm Ops Officer |
|
2020-08-20 |
4 |
D |
$18.22 |
$76,779 |
D/D |
(4,214) |
405,894 |
0 |
- |
|
TBPH |
Theravance Biopharma, Inc... |
SVP, Chief Comm Ops Officer |
|
2020-05-20 |
4 |
D |
$26.67 |
$112,387 |
D/D |
(4,214) |
410,108 |
0 |
- |
|
TBPH |
Theravance Biopharma, Inc... |
SVP, Chief Comm Ops Officer |
|
2020-02-20 |
4 |
D |
$25.90 |
$631,753 |
D/D |
(24,392) |
412,920 |
0 |
- |
|
TBPH |
Theravance Biopharma, Inc... |
SVP, Chief Comm Ops Officer |
|
2020-02-03 |
4 |
A |
$0.00 |
$0 |
D/D |
119,000 |
437,312 |
0 |
- |
|
TBPH |
Theravance Biopharma, Inc... |
SVP, Chief Comm Ops Officer |
|
2019-11-20 |
4 |
D |
$17.60 |
$43,067 |
D/D |
(2,447) |
318,312 |
0 |
- |
|
TBPH |
Theravance Biopharma, Inc... |
SVP, Chief Comm Ops Officer |
|
2019-08-20 |
4 |
D |
$21.51 |
$50,226 |
D/D |
(2,335) |
320,759 |
0 |
- |
|
TBPH |
Theravance Biopharma, Inc... |
SVP, Chief Comm Ops Officer |
|
2019-05-20 |
4 |
D |
$19.84 |
$31,823 |
D/D |
(1,604) |
323,094 |
0 |
- |
|
TBPH |
Theravance Biopharma, Inc... |
SVP, Chief Comm Ops Officer |
|
2019-02-20 |
4 |
D |
$27.00 |
$132,813 |
D/D |
(4,919) |
323,671 |
0 |
- |
|
TBPH |
Theravance Biopharma, Inc... |
SVP, Chief Comm Ops Officer |
|
2019-02-05 |
4 |
A |
$0.00 |
$0 |
D/D |
112,250 |
328,590 |
0 |
- |
|
TBPH |
Theravance Biopharma, Inc... |
SVP, Chief Comm Ops Officer |
|
2018-11-20 |
4 |
D |
$24.79 |
$142,171 |
D/D |
(5,735) |
216,340 |
0 |
- |
|
TBPH |
Theravance Biopharma, Inc... |
SVP, Chief Comm Ops Officer |
|
2018-08-20 |
4 |
D |
$26.95 |
$154,558 |
D/D |
(5,735) |
222,075 |
0 |
- |
|
TBPH |
Theravance Biopharma, Inc... |
SVP, Chief Comm Ops Officer |
|
2018-05-20 |
4 |
D |
$24.31 |
$447,887 |
D/D |
(18,424) |
227,810 |
0 |
- |
|
TBPH |
Theravance Biopharma, Inc... |
SVP, Chief Comm Ops Officer |
|
2018-05-14 |
4 |
A |
$0.00 |
$0 |
D/D |
33,750 |
246,234 |
0 |
- |
|
TBPH |
Theravance Biopharma, Inc... |
SVP, Chief Comm Ops Officer |
|
2018-02-20 |
4 |
D |
$29.09 |
$137,916 |
D/D |
(4,741) |
211,619 |
0 |
- |
|
TBPH |
Theravance Biopharma, Inc... |
SVP, Chief Comm Ops Officer |
|
2018-02-12 |
4 |
A |
$0.00 |
$0 |
D/D |
9,000 |
216,360 |
0 |
- |
|
TBPH |
Theravance Biopharma, Inc... |
SVP, Chief Comm Ops Officer |
|
2017-11-20 |
4 |
D |
$28.58 |
$166,336 |
D/D |
(5,820) |
207,360 |
0 |
- |
|
TBPH |
Theravance Biopharma, Inc... |
SVP, Chief Comm Ops Officer |
|
2017-08-21 |
4 |
B |
$26.34 |
$105,359 |
D/D |
4,000 |
213,180 |
2.74 |
- |
|
TBPH |
Theravance Biopharma, Inc... |
SVP, Chief Comm Ops Officer |
|
2017-08-20 |
4 |
D |
$27.40 |
$159,468 |
D/D |
(5,820) |
209,180 |
0 |
- |
|
TBPH |
Theravance Biopharma, Inc... |
SVP, Chief Comm Ops Officer |
|
2017-05-20 |
4 |
D |
$36.83 |
$214,351 |
D/D |
(5,820) |
215,000 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|